Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Adds to Chemistry Product Line with $35M Biotage Acquisition

NEW YORK, Oct. 14 (GenomeWeb News) - Pyrosequencing said today that it has entered into an agreement with Dyax to acquire Biotage, a wholly owned subsidiary of Dyax that specializes in small-molecule purification and separation systems, for approximately $35 million in cash.

Pyrosequencing, which expanded its product line to include medicinal chemistry following its recent acquisition of Personal Chemistry, said the Biotage acquisition would enhance its chemistry portfolio.

Pyrosequencing said it plans to take over the mortgage on Biotage's newly built premises in Virginia, which will reduce the purchase price to approximately $30 million.

Biotage reported net sales of $23.2 million in 2002. The company has 126 employees.


The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.